Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 27 Parkinson Disease 4, Autosomal Dominant Lewy Body 24 Neoplasms 14 Melanoma 9 Endometrial Neoplasms 8 Carcinoma, Renal Cell 7 Carcinoma, Non-Small-Cell Lung 7 Thyroid Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 6 Cholangiocarcinoma 6 Stomach Neoplasms 4 Recurrence 4 Carcinoma 4 Biliary Tract Neoplasms 4 Ovarian Neoplasms 3 Neoplasm Metastasis 3 Lymphoma 3 Colorectal Neoplasms 3 Triple Negative Breast Neoplasms 2 Paraganglioma, Extra-Adrenal 2 Osteosarcoma 2 Neuroendocrine Tumors 2 Lung Neoplasms 2 Liver Neoplasms 2 Glioma 2 Esophageal Neoplasms 2 Carcinoma, Transitional Cell 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thyroid cancer, Hurthle cell 1

Interventions

Doxorubicin 80 Ifosfamide 54 Radiotherapy 43 Filgrastim 41 Gemcitabine 38 Cyclophosphamide 34 Etoposide 26 Vincristine 24 Cisplatin 24 Docetaxel 23 pazopanib 21 Trabectedin 19 Carboplatin 17 pembrolizumab 15 Peripheral Blood Stem Cell Transplantation 14 eribulin 12 Mesna 12 Melphalan 12 Sorafenib 11 Sirolimus 11 Irinotecan 11 Granulocyte Colony-Stimulating Factor 11 Bevacizumab 11 Topotecan 10 Paclitaxel 10 Imatinib Mesylate 10 Chemotherapy, Adjuvant 10 pegfilgrastim 9 Temozolomide 9 Surgical Procedures, Operative 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Sarcoma × lenvatinib × Clear all

NCT03526679 2025-12-05

LEADER

National Taiwan University Hospital

Phase 1/2 Completed

30 enrolled 9 charts

Leiomyosarcoma, Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡